Financhill
Back

Design Therapeutics Quote, Financials, Valuation and Earnings

Design Therapeutics Price Quote

$5.63
+0.09 (+1.62%)
(Updated: September 16, 2024 at 2:50 PM ET)

Design Therapeutics Key Stats

Buy
52
Design Therapeutics (DSGN) is a Buy

Day range:
$5.20 - $5.97
52-week range:
$1.96 - $6.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.2%

Volume:
291.1K
Avg. volume:
344.9K
1-year change:
107.49%
Market cap:
$313.7M
Revenue:
$0
EPS:
$-0.9

How Much Does Design Therapeutics Make?

Data Unavailable

Is Design Therapeutics Growing As A Company?

Data Unavailable

Design Therapeutics Stock Price Performance

What Is Design Therapeutics 52-Week High & Low?

Design Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Design Therapeutics?

Is Design Therapeutics Cash Flow Positive?

  • What Is DSGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$51M
  • What Is Design Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $763K
  • What Is Design Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $68.8M

Design Therapeutics Return On Invested Capital

Data Unavailable

Design Therapeutics Earnings Date & Stock Price

Design Therapeutics Competitors

  • Who Are Design Therapeutics's Competitors?
    Below is a list of companies who compete with Design Therapeutics or are related in some way:
    • Biogen Inc (BIIB)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PTC Therapeutics Inc (PTCT)
    • Palatin Technologies Inc (PTN)
    • Voyager Therapeutics Inc (VYGR)

Design Therapeutics Dividend Yield

Design Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 26.35%

Major Shareholders

  • How many DSGN shares are owned by institutional investors?
    41.2M DSGN shares are owned by institutional investors
  • How many DSGN shares are owned by insiders?
    1.2M DSGN shares are owned by insiders